MENU
MLTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MoonLake Immunotherapeutics (MLTX) Ownership - Who owns MoonLake Immunotherapeutics?
Profile
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.55B
P/E Ratio
N/A
Total Cash
493.92M
Projected Growth
N/A
Total Debt
3.69M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.83
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MLTX
Capitalization
3.55B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
494M
Total Cash/Share
7.83
Total Debt
3.69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
488M
P/B Ratio
7.27
Cash Flow
N/A
Earnings
-1.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.39K
Current Ratio
25.51
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-108.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.86
Shares Held By Institutions
5.67B
Shares Outstanding - Current
63.1M
Total Liabilities
22.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-6.773
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
50
Web
https://www.moonlaketx.com